Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Ganciclovir for CMV Anterior Uveitis/Endotheliitis
NCT02943057Phase 4Completed
- Sponsor
- Singapore National Eye Centre
- Start
- Oct 2016
- Primary completion
- Jan 2024
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of ganciclovir in Cytomegalovirus anterior uveitis, cytomegalovirus endotheliitis (CMVE), sponsored by Singapore National Eye Centre. Started Oct 2016; status: completed.
02
Drugs
ganciclovir
03
Conditions
Cytomegalovirus anterior uveitiscytomegalovirus endotheliitis (CMVE)
Beyond the preview
Go deeper on NCT02943057.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02943057.